Showing results (111-120 of 1,009) with videos related to
Sort By:
Pageof 101
Cancer Research Communications|June 18, 2024
Zinc-alpha-2-glycoprotein Secreted by Triple-Negative Breast Cancer Promotes Peritumoral FibrosisSurbhi Verma, Stephanie D Giagnocavo, Meghan C Curtin, et al.Cancer Research Communications|April 30, 2024
Novel Spirocyclic Dimer, SpiD3, Targets Chronic Lymphocytic Leukemia Survival Pathways with Potent Preclinical EffectsAlexandria P Eiken, Audrey L Smith, Sydney A Skupa, et al.Cancer Research Communications|June 10, 2024
Race-Related Differences in Sipuleucel-T Response among Men with Metastatic Castrate-Resistant Prostate CancerElisabeth I Heath, Archana Thakur, Wei Chen, et al.Cancer Research Communications|June 5, 2024
Cancer-related Fatigue and the Additive Effect of Treatment in the Context of Lymphoma: An Analysis of the Lymphoma Coalition's 2022 Global Patient SurveySteve E Kalloger, Amanda Watson, Shawn Sajkowski, et al.Cancer Research Communications|June 5, 2024
Activation of the Mevalonate Pathway in Response to Anti-cancer Treatments Drives Glioblastoma Recurrences Through Activation of Rac-1Ling He, Angeliki Ioannidis, Carter J Hoffman, et al.Cancer Research Communications|May 10, 2024
Epigenetic Priming by Hypomethylation Enhances the Immunogenic Potential of Tolinapant in T-cell LymphomaGeorge A Ward, Zhiqiang Zhang, Simone Jueliger, et al.Cancer Research Communications|April 23, 2024
The FKBP51s Splice Isoform Predicts Unfavorable Prognosis in Patients with GlioblastomaCarolina Giordano, Laura Marrone, Simona Romano, et al.Cancer Research Communications|April 19, 2024
Synergy of EGFR and AURKA Inhibitors in KRAS-mutated Non-small Cell Lung CancersTetyana Bagnyukova, Brian L Egleston, Valerii A Pavlov, et al.Cancer Research Communications|April 10, 2024
Impact of Surgery-Induced Myeloid-derived Suppressor Cells and the NOX2/ROS Axis on Postoperative Survival in Human Pancreatic CancerHanna Grauers Wiktorin, Ebru Aydin, Roberta Kiffin, et al.Cancer Research Communications|April 9, 2024
Inhibition of NEK2 Promotes Chemosensitivity and Reduces KSHV-positive Primary Effusion Lymphoma BurdenMaria C White, Jason P Wong, Blossom DamaniaPageof 101